FDA recall, , Moderate risk
Preferred Pharmaceuticals Artificial Tears Lubricant Eye Drops
Artificial Tears Lubricant Eye Drops lack assurance of sterility.
Summary by Recall Canary from the FDA notice
What happened
Preferred Pharmaceuticals, Inc., of Anaheim, California, voluntarily recalled Artificial Tears Lubricant Eye Drops, Visine, Pkg Size: 15, manufactured by Geri-Care of Brooklyn, NY, due to a lack of assurance of sterility. The recall, initiated on October 16, 2026, involved 480 bottles distributed nationwide in the U.S. The FDA added the recall to its Enforcement Report and classified it on October 30, 2026.
Customers were notified by letter. The recall was firm-initiated and voluntary.
What to do
The FDA notice gives no instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match the NDC and lot code listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
Artificial Tears Lubricant Eye Drops, Visine
- NDC
- 68788-7266-0
- Lot code
- C2825L
- G1825U
- D0826A
- D1326B
Recall details
- Posted by FDA
- Recall began
- Status
- Open
- Weekly archive
- Listed the week of Oct 26, 2026
- Sold in
U.S. Nationwide
- Recalled by
- Preferred Pharmaceuticals, Inc.Anaheim, California
- Hazard
- Sterility problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- FDA event number
- 100159
- Recall number
- D-0158-2027
- Quantity recalled
- 480 bottles
- Recall type
- Voluntary: Firm initiated
- How the company first told customers
- Letter
All recalls from Preferred Pharmaceuticals, Inc.
Timeline
FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.
Preferred Pharmaceuticals, Inc. began the recall
FDA posted the recall to its Enforcement Report and rated it Class II (moderate risk)
Added to Recall Canary
